Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Pharmacol ; 49(1): 89-96, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9120777

ABSTRACT

Acute and long-term neurochemical effects of aminorex, an appetite-suppressing drug related to amphetamine in chemical structure, and stereoisomers of its analogues were examined and compared with those of 3.4-methylenedioxymethylamphetamine (MDMA) and fenfluramine. Aminorex and its analogues, with exception of 4S, 5S-dimethylaminorex, did not cause the long-term neurotransmitter depletion in either the dopaminergic or 5-HT-ergic systems that was observed after MDMA or fenfluramine in CBA mice. These results are discussed in terms of possible structurally related mechanisms of neurotoxicity. The acute neurochemical effects showed that aminorex and analogues all produced increases in 5-hydroxytryptamine (5-HT) levels, unlike fenfluramine and MDMA in the present study or in published data. This suggests that inhibition of 5-HT metabolism, rather than direct 5-HT release, may be involved in their anorectic effect. The parallel study of acute dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) changes suggest that in CBA mice MDMA may be a better dopamine releaser and this may contribute to its dopaminergic neurotoxicity. However the ability to release dopamine or 5-HT, or both, may be important, but not the only factor involved in causing the long-term neurotoxicity observed with amphetamine derivatives.


Subject(s)
Aminorex/toxicity , Appetite Depressants/toxicity , Biogenic Monoamines/analysis , Brain Chemistry/drug effects , 3,4-Dihydroxyphenylacetic Acid/analysis , Animals , Biogenic Monoamines/metabolism , Dopamine/analysis , Hydroxyindoleacetic Acid/analysis , Male , Mice , Mice, Inbred CBA , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Serotonin/analysis
2.
Arch Toxicol Suppl ; 8: 131-41, 1985.
Article in English | MEDLINE | ID: mdl-3006632

ABSTRACT

The mechanisms by which xenobiotics may cause or promote thrombosis include vascular damage, induction of a hypercoagulable state and disturbances of blood flow. This paper discusses the methods available to detect various types of thrombogenic substances. Pathomorphological techniques are best suited to demonstrate thrombosis caused by localized vascular damage or generalized endothelial lesions. For the assessment of disseminated microcirculatory thrombosis, the consumption of platelets and clotting factors and the appearance of specific platelet proteins and fibrinogen and fibrin split products can be determined in the blood. Hypercoagulability which is defined as a perturbation of the hemostatic equilibrium resulting in a shift in the direction of thrombosis, is of particular importance in toxicology. Many in vitro, ex vivo and in vivo methods have been proposed to detect and to measure the ability of xenobiotics to induce a prethrombotic state. Their usefulness is demonstrated with several examples.


Subject(s)
Thromboembolism/chemically induced , Adrenocorticotropic Hormone/toxicity , Aminorex/toxicity , Animals , Blood Coagulation Disorders/chemically induced , Blood Coagulation Tests , Caffeine/toxicity , Endothelium/drug effects , Fatty Acids/blood , Female , Guanethidine/toxicity , Guinea Pigs , Male , Nicotine/toxicity , Norepinephrine/toxicity , Platelet Aggregation/drug effects , Research Design , Thromboembolism/classification , Vasculitis/chemically induced , Vasculitis/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...